News | Cardiovascular Business | March 15, 2019

ACC Combines NCDR, Accreditation Into New Quality Summit

ACC Quality Summit examines role of registries, quality campaigns and accreditation in quality and performance improvement efforts

ACC Combines NCDR, Accreditation Into New Quality Summit

March 15, 2019 — The American College of Cardiology’s first annual ACC Quality Summit, held March 13-15 in New Orleans, merges the NCDR (National Cardiovascular Data Registry) Annual Conference and ACC Accreditation Congress for the first time to optimize cardiovascular patient care. The conference brings together cardiovascular thought leaders, administrators, clinicians, clinical quality leaders and data quality experts.

“The ACC Quality Summit bridges quality improvement projects to improving cardiovascular care and patient outcomes. We’re excited to bring together NCDR and Accreditation and achieve quality care by connecting the entire healthcare team to share their success stories,” said Ralph Brindis, M.D., MPH, MACC, co-director of ACC Quality Summit. “Whether you’re a CV admin seeking innovative solutions to improve your service line, a physician interested in promoting CV quality or a hospital administrator who wants to learn how NCDR/Accreditation can support your strategic goals, ACC Quality Summit has education and networking opportunities for all audiences, roles and experience levels.”

At ACC Quality Summit, cardiovascular professionals who participate in the NCDR, ACC Quality Campaigns or have achieved ACC Accreditation, will learn more about effectively translating data and quality programs into achieving care. Cardiovascular leaders and experts will help attendees focus on providing optimal patient care, achieving clinical outcomes excellence and capturing high-quality data to drive important clinical and service line decisions.

Zubin Damania, M.D., this year’s Ralph G. Brindis Keynote speaker, will discuss the importance of a team approach to quality and safety. Also known as “ZDoggMD,” Damania is an internist and comedian known for educating patients and providers through satirizing the healthcare system.

Attendees submitted abstracts telling the story of changes they have implemented in their organization, including quality improvement projects, education approaches, innovative processes and research. The following abstracts are a selection of the posters being presented:

  • Improving Medication Communication;
  • Preparing for the Storm of Obstacles;
  • Cardiovascular Care from the Frontier;
  • The Village Concept in Cardiac Rehab; and
  • Utilization of a Mobile Integrated Health Model.

This year three abstracts were selected for oral presentation during a general session at ACC Quality Summit:

  • Bleeding Avoidance Strategies in Cardiac Catheterization Procedures – A Single Center Experience;
  • Early Follow Up Post AMI Discharge and the Impact on Readmission Rate;
  • Experience from the ACC Patient Navigator Program; and
  • Improving the Utilization of i-STAT Troponin in Chest Pain Patients Quality Improvement Initiative

For more information: www.cvquality.acc.org

Related Content

American College of Cardiology Names Douglas Drachman Next Annual Scientific Session Vice Chair

Image courtesy of Massachusetts General Hospital

News | ACC | October 08, 2019
Douglas Drachman, M.D., FACC, has been selected as the next vice chair of the American College of Cardiology’s (ACC)...
SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions. FFR in the cath lab.

SyncVision iFR Co-registration from Philips Healthcare maps pressure readings onto angiogram. Results from an international study presented at ACC 2019 indicates pressure readings obtained using iFR (instantaneous wave-free ratio, also referred to as instant wave-free ratio or instant flow reserve) in coronary arteries may localize stenoses that remain after interventions.

Feature | ACC | March 27, 2019 | Greg Freiherr, Contributing Editor
The fingerprints of value-added medicine were all over products and works-in-progress on the exhibit floor of the a

The opening late-breaking trial at ACC 2019 is the Apple Heart Study, a large-scale, app-based study to identify atrial fibrillation using a smartwatch. Earlier, smaller trials showed this approach might be used in a population health application to proactively identify AFib patients earlier.

Feature | ACC | March 19, 2019
The American College of Cardiology (ACC) released a list of the late
A patient who received HeartMate III LVAD system at ACC.18. The HeartMate 3 was the topic of of the the key late-breaking trials at #ACC18

A patient who received the HeartMate III LVAD system showing off his external battery pack. He served as a patient ambassador in the Abbott booth at ACC.18. The HeartMate III, with its magnetic levitated pump, showed a big reduction in clotting over previous LVADs in a key late-breaking trial at this year's conference.

Feature | ACC | March 27, 2018 | Dave Fornell
There were several notable presentations of new data on cardiovascular technologies at the recent 2018 American Colle
Drug Stops Dangerous Bleeding in Patients Taking Factor Xa Inhibitors

Connolly 

News | ACC | March 22, 2018
March 22, 2018 — The experimental drug...
Videos | ACC | March 21, 2018
DAIC Editor Dave Fornell takes a tour of some of the most interesting new technologies on the expo floor at
ACC 2018 Late-Breaking Trials Announced
News | ACC | March 21, 2018
Here is a list of the American College of Cardiology (ACC) 2018 annual meeting late-breaking clinical trials presente
Inhaled Therapy Ineffective in Difficult-to-Treat Heart Failure at ACC 2018.

Image from presentation, "Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF: The INDIE-HFpEF Trial," Borlaug

News | ACC | March 20, 2018
March 20, 2018 — Four weeks of treatment with a novel inhaled medication failed to improve exercise capacity, daily a
More Deaths, Strokes Seen with Perioperative Beta Blocker One Year After Surgery

Image from presentation, "1-Year outcomes of perioperative beta-blockade in patients undergoing noncardiac surgery," Devereaux 

News | ACC | March 20, 2018
March 20, 2018 — During the 12 months after undergoing noncardiac surgery, patients with or at risk for heart disease
Trial for Gout Drug Meets Primary Endpoint, Raises Safety Concerns, image shows a CT scan showing gout in the knees.
News | ACC | March 20, 2018
March 20, 2018 — Febuxostat, a gout dr...
Overlay Init